A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3551-3559

  Hall, Lisa L ^a   Th'ng, John P H ^b   Guo, Xiao Wen ^a   Teplitz, Raymond L ^a   Bradbury, E Morton ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAUROSPORINE;

ANIMAL CELL; ARTICLE; CANCER; CELL CYCLE; DRUG EFFECT; MITOSIS; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; CDC2 PROTEIN KINASE; DNA, NEOPLASM; ENZYME INHIBITORS; G1 PHASE; HISTONES; MAMMARY NEOPLASMS, EXPERIMENTAL; METAPHASE; MICE; MITOSIS; NOCODAZOLE; PHOSPHORYLATION; POLYPLOIDY; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0029680383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Hartwell, L., and Weinert, T. Genetic control of mitotic fidelity in yeast and its relation to cancer. In: J. Brugge, T. Curran, E. Harlow, and F. McCormic (eds.), Origins of Human Cancer: A Comprehensive Review, pp. 45-49. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1991.
2. Brodskii, V. I. Genome multiplication in growth and development biology of polyploid and polytene cells. In: V. Y. Brodsky and I. V. Uryvaeva, Developmental and Cell Biology Series 15. Cambridge, United Kingdom: Cambridge University Press, 1985.
3. Holliday, R. Chromosome error propagation and cancer. Trends Genet., 5: 42-45, 1989.
4. Auer, G. U., Fallenius, A. G., Erhardt, K. Y., and Sundelin, B. S. Progression of mammary adenocarcinomas as reflected by nuclear DNA content. Cytometry, 5: 420-425, 1984.
5. Dobashi, K., Stratton, J. A., Teplitz, R. L., Liao, S. Y., Braly, P. S., and Disaia, P. J. Quantitative nuclear DNA analysis of human ovarian adenocarcinoma: compared before and after chemotherapy and correlated with clinical response. Gyn. Oncol., 24: 81-90, 1986.
6. Auer, G., Eriksson, E., Azavedo, E., Caspersson, T., and Wallgren, A. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res., 44: 394-396, 1984.
7. Wersto, R. P., Liblit, R. L., and Koss, L. G. Flow cytometric DNA analysis of human solid tumors a review of the interpretation of DNA histograms. Hum. Pathol., 22: 1085-1098, 1991.
8. Koss, L. G. Quantitative and analytical cytology in historical perspective. J. Cell. Biochem. Suppl., 19: 23-27, 1994.
9. Blankenberg, F. G., Teplitz, R. L., Ellis, W., Salamat, S., Min, B. H., Hall, L., Boothroyd, D. B., Johnstone, I. M., and Enzmann, D. R. The influence of volumetric tumor doubling time DNA, ploidy and histologic grade on the survival of patients with intracranial astrocytomas Am. J. Neuroradiol., 16: 1001-1012, 1995.
10. Pak, H. Y., Yokota, S., Teplitz, R. L., Shaw, S. L., and Werner, J. L. Rapid staining techniques employed in fine needle aspirations of the lung Acta Cytol., 25: 178-184, 1981.
11. Pak, H. Y., Teplitz, R. L., Ashdjian, V., Yokota, S. B., Hammond, W. G., and Benfield, J. R. Quantitative DNA determination by image analysis. II. Application to human and canine pulmonary cytology. Anal. Quant. Cytol., 5: 263-268, 1983.
12. Teplitz, R. L., Butler, B. B., Tesluk, H., Min, B. H., Russell, L. A., Jensen, H. M., and Hill, L. R. Quantitative DNA patterns in human preneoplastic breast lesions Anal. Quant. Cytol. Histol., 12: 98-102, 1990.
13. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
14. Bezooijen, C. F., van Leeuw-Israel, F. R., and de Hollander, C. F. On the role of hepatic cell ploidy in changes in liver function with age and following partial hepatectomy. Mech. Ageing Dev., 1: 351-356, 1973.
15. Schlatterer, B., and Paul, H. S. Influence of thyroid hormones on the number of nucleoli and the degree of polyploidy in rat liver. Acta Anat., 90: 563-572, 1974.
16. Pak, H. Y., Ashdjian, V., Yokota, S. B., and Teplitz, R. L. Quantitative DNA determination by image analysis. Anal. Quant. Cytol., 4: 95-98, 1982.
17. Moreno, S., and Nurse, P. Regulation of progression through the G1 phase of the cell cycle by the rum1+ gene. Nature (Lond.), 367: 236-242, 1994.
18. Broek, D., Bartlett, R., Crawford, K., and Nurse, P. Involvement of p34cdc2 in establishing the dependency of S phase on mitosis. Nature (Lond.), 349: 388-393, 1991.
19. Hayles, J., Fisher, D., Woollard, A., and Nurse, P. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex Cell, 78: 813-822, 1994.
20. Correa-Bordes, J., and Nurse, P. p25rum1 orders S phase and mitosis by acting as an inhibitor of the p34cdc2 mitotic kinase. Cell, 83: 1001-1009, 1995.
21. Grafi, G., and Larkins, B. A. Endoreduplication in maize endosperm: involvement of M phase-promoting factor inhibition and induction of S phase-related kinases. Science (Washington DC), 269: 1263-1264, 1995.
22. Waters, C. Inducible entry into the cell cycle in the mouse parotid gland, Ph.D. dissertation, University of California at Davis, 1994.
23. Norbury, C., and Nurse, P. Controls of cell proliferation in yeast and animals. Ciba Found. Symp., 150: 168-177, 1990.
24. Bradbury, E. M., Inglis, R. J., and Matthews, H. R. Control of cell division by very lysine rich histone (F1) phosphorylation. Nature (Lond.), 247: 257-261, 1974.
25. Bradbury, E. M., Inglis, R. J., Matthews, H. R., and Langan, T. A. Molecular basis of control of mitotic cell division in eukaryotes. Nature (Lond.), 249: 553-556, 1974.
26. Langan, T. A., Gautier, J., Lohka, M., Hollingsworth, R., Moreno, S., Nurse, P., Maller, J., and Sclafani, R. A. Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells. Mol. Cell. Biol., 9: 3860-3868, 1989.
27. Doree, M., Labbe, J. C., and Picard, A. M phase-promoting factor: its identification as the M phase-specific H1 histone kinase and its activation by dephosphorylation. J. Cell Sci. Suppl., 12: 39-51, 1989.
28. Enoch, T., Peter, M., Nurse, P., and Nigg, E. A. p34cdc2 acts as a lamin kinase in fission yeast. J. Cell Biol., 112: 797-807, 1991.
29. Peter, M., Heitlinger, E., Haner, M., Aebi, U., and Nigg, E. A. Disassembly of in vitro formed lamin head-to-tail polymers by CDC2 kinase EMBO J., 10: 1535-1544, 1991.
30. Luscher, B., Brizuela, L., Beach, D., and Eisenman, R. N. A role for the p34cdc2 kinase and phosphatases in the regulation of phosphorylation and disassembly of lamin B2 during the cell cycle EMBO J., 10: 865-875, 1991.
31. Nigg, E. A. Assembly and cell cycle dynamics of the nuclear lamina. Semin. Cell Biol., 3: 245-253, 1992.
32. Labib, K., Craven, R. A., Crawford, K., and Nurse, P. Dominant mutants identify new roles for p34cdc2 in mitosis EMBO J., 14: 2155-2165, 1995.
33. Compton, D. A., and Luo, C. Mutation of the predicted p34cdc2 phosphorylation sites in NuMA impair the assembly of the mitotic spindle and block mitosis. J. Cell Sci., 108: 621-633, 1995.
34. Sawin, K. E., and Mitchison, T. J. Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc. Natl. Acad. Sci. USA, 92: 4289-4293, 1995.
35. Satterwhite, L. L., Lohka, M. J., Wilson, K. L., Scherson, T. Y., Cisek, L. J., Corden, J. L., and Pollard, T. D. Phosphorylation of myosin-II regulatory light chain by cyclin-p34cdc2: a mechanism for the timing of cytokinesis. J. Cell Biol., 118: 595-605, 1992.
36. Hosoya, N., Hosoya, H., Yamashiro, S., Mohri, H., and Matsumura, F. Localization of caldesmon and its dephosphorylation during cell division. J. Cell Biol., 121: 1075-1082, 1993.
37. Ookata, K., Hisanaga, S., Bulinski, J. C., Murofushi, H., Aizawa, H., Itoh, T. J., Hotani, H., Okumura, E., Tachibana, K., and Kishimoto, T. Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol., 128: 849-862, 1995.
38. Booher, R., and Beach, D. Involvement of cdc13+ in mitotic control in Schizosaccharomyces pombe: possible interaction of the gene product with microtubules. EMBO J., 7: 2321-2327, 1988.
39. Kung, A. L., Sherwood, S. W., and Schimke, R. T. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA, 87: 9553-9557, 1990.
40. Yamada, K., and Kimura, G. Formation of proliferative tetraploid cells after treatment of diploid cells with sodium butyrate in rat 3Y1 fibroblasts. J. Cell. Physiol., 122: 59-63, 1985.
41. Yamada, K., Ohtsu, M., and Kimura, G. Isolation of tetraploid clones with high efficiency from diploid 3Y1 rat fibroblasts treated with sodium butyrate. In Vitro Cell. Dev. Biol., 21: 428-432, 1985.
42. Yoshida, M., Horinouchi, S., and Beppu, T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays, 221: 227-236, 1995.
43. Ishida, R., Sato, M., Narita, T., Utsumi, K. R., Nishimoto, T., Morita, T., Nagata, H., and Andoh, T. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J. Cell Biol., 126: 1341-1351, 1994.
44. Usui, T., Yoshida, M., Abe, K., Osada, H., Isono, K., and Beppu, T. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor K-252a. J. Cell Biol., 115: 1275-1282, 1991.
45. Bruno, S., Ardelt, B., Skierski, J. S., Traganos, F., and Darzynkiewicz, Z. Different effects of staurasporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res., 52: 470-473, 1992.
46. 3H]staurosporine on various protein kinases. Biochem. Biophys. Res. Commun., 171: 189-195, 1990.
47. ++-dependent protein kinase. Biochem. Biophys. Res. Commun., 135: 397-402, 1986.
48. Fallon, R. J. Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes. Biochem. Biophys. Res. Commun., 170: 1191-1196, 1990.
49. Nakano, H., Kobayashi, E., Takahashi, I., Tamaoki, T., Kuzuu, Y., and Iba, H. Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60 J. Antibiot. (Tokyo), 40: 706-708, 1987.
50. Gadbois, D. M., Hamaguchi, J. R., Swank, R. A., and Bradbury, E. M. Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases Biochem. Biophys. Res. Commun, 184: 80-85, 1992.
51. Abe, K., Yoshida, M., Usui, T., Horinouchi, S., and Beppu, T. Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp. Cell Res., 192: 122-127, 1991.
52. Crissman, H. A., Gadbois, D. M., Tobey, R. A., and Bradbury, E. M. Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA, 88: 7580-7584, 1991.
53. Gadbois, D. M., Crissman, H. A., Tobey, R. A. and Bradbury, E. M. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. USA, 89: 8626-8630, 1992.
54. Th'ng, J. P., Guo, X. W., Swank, R. A., Crissman, H. A., and Bradbury, E. M. Inhibition of histone phosphorylation by staurosporine leads to chromosome decondensation. J. Biol. Chem., 269: 9568-9573, 1994.
55. Tobey, R. A., and Ley, K. D. Isoleucine-mediated regulation of genome replication in various mammalian cell lines. Cancer Res., 31: 46-51, 1971.
56. Guo, X. W., Th'ng, J. P. H., Swank, R. A., Anderson, H. J., Tudan, C., Bradbury, E. M., and Roberge, M. Chromosome condensation induced by fostriecin does not require p34CDC2 kinase activity and histone H1 phosphorylation but is associated with enhanced H2A and H3 phosphorylation. EMBO J., 14: 976-985, 1995.
57. Th'ng, J. P., Wright, P. S., Hamaguchi, J., Lee, M. G., Norbury, C. J., Nurse, P., and Bradbury, E. M. The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell, 63: 313-324, 1990.
58. Bradbury, E. M., Inglis, R. J., Matthews, H. R., and Sarner, N. Phosphorylation of very-lysine-rich histone in Physarum polycephalum: correlation with chromosome condensation. Eur. J. Biochem., 33: 131-139, 1973.
59. Gurley, L. R., Walters, R. A. Barham, S. S., and Deaven, L. L. Heterochromatin and histone phosphorylation. Exp. Cell Res., 111: 373-383, 1978.
60. Cairns, J. The origin of human cancers Nature (Lond.), 289: 353-357, 1981.
61. Solomon, E. Borrow, J., and Goddard, A. D. Chromosome aberrations and cancer Science (Washington DC), 254: 1153-1160, 1991.
62. Yunis, J. J. The chromosomal basis of human neoplasia. Science (Washington DC), 221: 227-236, 1983.
63. Sandberg, A. A. A chromosomal hypothesis of oncogenesis. Cancer Genet. Cytogenet., 8: 277-285, 1983.
64. Gallant, P., and Nigg, E. A. Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J. Cell Biol., 117: 213-224, 1992.
65. Sherwood, S. W., Kung, A. L., Roitelman, J., Simoni, R. D., and Schimke, R. T. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. Cell Biol., 90: 3353-3357, 1993.
66. Sudakin, V., Ganoth, D., Dann, A., Heller, H., Hershko, J., Luca, F. C., Ruderman, J. V., and Hershko, A. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis Mol. Biol. Cell, 6: 185-197, 1995.
67. Nishimoto, T., Uzawa, S., and Schlegel, R. Mitotic checkpoints. Curr. Opin. Cell Biol., 4: 174-179, 1992.
68. Gu, Y., Rosenblatt, J., and Morgan, D. O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J., 11: 3995-4005, 1992.
69. Blow, J. J., and Laskey, R. A. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature (Lond.), 332: 546-548, 1988.
70. Leno, G. H., Downes, C. S., and Laskey, R. A. The nuclear membrane prevents replication of human G2 nuclei but not G1 nuclei in Xenopus egg extract. Cell, 69: 151-158, 1992.
71. Madine, M. A., Khoo, C. Y., Mills, A. D., and Laskey, R. A. MCM3 complex required for cell cycle regulation of DNA replication in vertebrate cells. Nature (Lond.), 375: 421-424, 1995.
72. Chong, J. P. J., Mahbubani, H. M., Khoo, C. Y., and Blow, J. J. Purification of an MCM-containing complex as a component of the DNA replication licensing system. Nature (Lond.), 375: 418-421, 1995.
73. Lewin, B. Chromatin and gene expression: constant questions, but changing answers Cell, 79: 397-406, 1994.
74. Hirschberg, J., and Marcus, M. Isolation by a replica-plating technique of Chinese hamster temperature-sensitive cell cycle mutants. J. Cell Physiol., 113: 159-166, 1982.
75. Handeli, S., and Weintraub, H. The ts41 mutation in Chinese hamster cells leads to successive S phases in the absence of intervening G2, M, and G1. Cell, 71: 599-611, 1992.
76. Zhang, Y., Wang, Z., and Ravid, K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J. Biol. Chem., 271: 4266-4272, 1996.